aod9604 fda approval status NBC News | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, AOD-9604 FDA Approval History

it's a potent non-stimulant small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT), an enzyme primarily found in adipose tissue and the liver

Their purpose is to help with metabolism and energy

The practical takeaway: AOD-9604 has a clean safety profile in trials but a failed Phase 2b efficacy endpoint

In rare cases, starting high-dose B12 treatments for severe anemia may cause temporary imbalances in potassium levels or an acne-like rash

Divide the dose 60/40 or 50/50 between morning (fasted) and evening (at least 2 hours after eating)

This range helps in treating different levels of deficiency safely